O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

J. Dumortier (1) , D. Botta-Fridlund , A. Coilly , V. Leroy , C. Fougerou-Leurent (2) , H. Danjou , S. Radenne , Franck Durand , Nassim Kamar (3, 4) , V. Di Martino , V. De Ledinghen , P. Houssel-Debry , L D’alteroche , C. Duvoux , F. Conti , V. Canva , A. Diallo , A. Rohel , J. -C. Duclos-Vallée , G. -P Pageaux

1 Département d'hépatologie
2 CIC - Centre d'Investigation Clinique [Rennes]
3 I2MR - Institut de médecine moléculaire de Rangueil
4 Département de Néphrologie et Transplantation d'organes [CHU Toulouse]

no abstract

Domaines: Sciences du Vivant [q-bio]

J. Dumortier, D. Botta-Fridlund, A. Coilly, V. Leroy, C. Fougerou-Leurent, et al.. O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study. The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S247--S248, ⟨10.1016/S0168-8278(15)30128-8⟩. ⟨hal-01162706⟩